0HQ1 Stock Overview
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Azenta, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$45.79 |
| 52 Week High | US$69.06 |
| 52 Week Low | US$39.24 |
| Beta | 1.48 |
| 11 Month Change | 12.00% |
| 3 Month Change | -8.37% |
| 1 Year Change | -21.09% |
| 33 Year Change | -58.72% |
| 5 Year Change | 23.66% |
| Change since IPO | 56.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HQ1 | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | 3.3% | -2.8% | 2.2% |
| 1Y | -21.1% | -29.3% | 8.0% |
Return vs Industry: 0HQ1 exceeded the UK Life Sciences industry which returned -29.3% over the past year.
Return vs Market: 0HQ1 underperformed the UK Market which returned 8% over the past year.
Price Volatility
| 0HQ1 volatility | |
|---|---|
| 0HQ1 Average Weekly Movement | 8.5% |
| Life Sciences Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HQ1's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0HQ1's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 3,300 | John P. Marotta | www.azenta.com |
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions.
Azenta, Inc. Fundamentals Summary
| 0HQ1 fundamental statistics | |
|---|---|
| Market cap | US$2.06b |
| Earnings (TTM) | -US$164.17m |
| Revenue (TTM) | US$656.32m |
3.1x
P/S Ratio-12.5x
P/E RatioIs 0HQ1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HQ1 income statement (TTM) | |
|---|---|
| Revenue | US$656.32m |
| Cost of Revenue | US$388.99m |
| Gross Profit | US$267.34m |
| Other Expenses | US$431.51m |
| Earnings | -US$164.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.60 |
| Gross Margin | 40.73% |
| Net Profit Margin | -25.01% |
| Debt/Equity Ratio | 0% |
How did 0HQ1 perform over the long term?
See historical performance and comparison